Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Feb. 28, 2018
Feb. 28, 2017
Revenues:    
Sales of health and beauty aid products - net $ 3,994,350 $ 4,265,078
Other income 4,074 4,073
Total Revenues 3,998,424 4,269,151
Costs and Expenses:    
Cost of sales 1,648,963 1,707,854
Selling, general and administrative expenses 1,845,239 1,625,378
Advertising, cooperative and promotional expenses 349,743 482,215
Research and development 14,514 13,082
Bad debt expense (recovery) 4,091 (9,931)
Interest expense 243,063 151,161
Total Costs and Expenses 4,105,613 3,969,759
(Loss) Income before Provision for Income Taxes (107,189) 299,392
Provision for Income taxes 3,113,470 112,640
Net (loss) income $ (3,220,659) $ 186,752
Basic    
(Loss) Income (usd per share) $ (0.45) $ 0.03
Diluted    
(Loss) Income (usd per share) $ (0.45) $ 0.03
Weighted Average Common Shares Outstanding    
Basic (shares) 7,126,684 7,006,684
Diluted (shares) 7,126,684 7,006,684